StockDrifts LogoStockDrifts

Medicox 054180

Company
메디콕스Medicox
Insiders
1
Buys
0
Total Value
₩24.6B ($17.1M)
Avg Return
-15.96%
Last Filing
2025-05-15

Medicox (054180) has 0 disclosed insider purchases and 3 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩24.6B ($17.1M) in reported transaction value. The earliest filing StockDrifts holds for Medicox is dated 2023-12-28; the most recent is 2025-05-15. Across these filings the average return since disclosure is -15.96%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-05-15SELLMarket Sell
제이케이시냅스
JK Synapse
--3.5M₩2,625+12.6%₩9.2B ($6.4M)
2025-05-14SELLMarket Sell
제이케이시냅스
JK Synapse
--2.9M₩2,025-13.3%₩5.9B ($4.1M)
2025-05-13SELLMarket Sell
제이케이시냅스
JK Synapse
--6.1M₩1,560-47.1%₩9.5B ($6.6M)
2025-03-13BUY제3자배정유상증자
케이지 투자조합
Cage Investment Association
-14.0M₩3,780-39.3%₩52.9B ($36.8M)
2023-12-28BUY제3자배정유상증자
제이케이시냅스
JK Synapse
-10.4M₩16,575-86.2%₩172.7B ($119.9M)

Frequently asked questions

Who has been buying Medicox stock?
1 distinct insiders have filed 0 disclosed insider purchases in Medicox (054180), most recently on 2025-05-15. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Medicox have?
Medicox has 0 buy-side and 3 sell-side disclosures on record, covering ₩24.6B ($17.1M) in total reported value, spanning 2023-12-28 to 2025-05-15.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.